0      0

AONN+ 2020 Midyear Virtual Conference


FRI02 - Industry Sponsored Session Presentation by Wellstat Therapeutics


May 15, 2020 12:30pm ‐ May 15, 2020 1:30pm

Standard: $15.00

Description

Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine

OBJECTIVES

  • Describe the incidence and burden of early-onset severe toxicity in patients receiving 5-FU and capecitabine
  • Describe mechanism of action of 5-FU and its cytotoxic metabolites as it relates to the causes of early-onset severe toxicity
  • Recognize signs and symptoms of 5-FU and capecitabine early-onset severe toxicity
  • Summarize evidence supporting emergency treatment for patients with early-onset severe toxicity and following 5-FU or capecitabine overdoses
  • Review the importance of prompt treatment of overdoses and early-onset severe toxicity
  • Educate patients, caregivers, and colleagues about the importance of recognizing and urgently treating early-onset severe toxicity of 5-FU or capecitabine

Speaker:

custom image
Alice Beers, BSN, OCN, RN-BC
Oncology Nurse Navigator
MedStar Georgetown Cancer Network at Washington Cancer Institute
MedStar Washington Hospital Center
Washington, DC

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content